Home / Financial Report / Security Firm Telos Eyes Expansion With New Investment From Enlightenment Capital

Security Firm Telos Eyes Expansion With New Investment From Enlightenment Capital

Enlightenment Capital has invested in Ashburn, Virginia-based information technology security company Telos in a move to help expand the latter’s portfolio of cybersecurity products and service offerings into new markets.

Telos said Tuesday it also plans to implement new technology research-and-development initiatives and explore merger/acquisition opportunities with financing support from Enlightenment Capital.

“It is a pleasure to work with an investment firm whose management team truly grasps the critical nature of our technologies and our key markets,” said Telos President and CEO John Wood.

Chevy Chase, Maryland-based Enlightenment Capital backs companies that serve the aerospace, defense and government sectors in the areas of critical infrastructure protection, cyber, data management, aerospace engineering and national security.

Telos works with military, intelligence, federal civilian and commercial organizations to help them secure information, systems and personnel as well as collaborates with Amazon Web Services (Nasdaq: AMZN) to help public and private sector clients manage critical resources in the cloud.

The security firm’s Xacta risk management and compliance platform is designed for organizations to address challenges related to migration into cloud or hybrid IT environments.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.